This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

SNMMI 2013 Image Of The Year Captured On GE Healthcare PET/CT Technology

GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 “Image of the Year.” To see the image, visit GE Healthcare’s Newsroom.

Professor Flamen’s winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.

According to SNMMI, it “chooses an image that exemplifies the most cutting-edge nuclear medicine or molecular imaging research today and that demonstrates the ability of molecular imaging to detect, diagnose and treat disease and help select the most appropriate therapy.”

“Congratulations to Professor Flamen on this stunning image demonstrating the power of molecular imaging,” said Steve Gray, president and CEO of GE Healthcare’s Molecular Imaging business. “The Institut Jules Bordet continues to be at the forefront of using this technology and GE Healthcare’s Discovery PET/CT 690 is excellent for the image quality and speed desired in these procedures.”

“At the Institut Bordet, we aim to provide excellence in both clinical and research activities and we are grateful to the SNMMI for this great recognition,” said Professor Flamen. “GE has been a longtime collaborator in providing great equipment, great applications, and great support, allowing us to achieve outstanding clinical throughput with more than 5,000 PET/CT studies per year on our GE Discovery PET/CT 690.”

Institut Jules Bordet, a GE PET/CT European reference center, has showcased its PET/CT imaging best practices to nuclear medicine physicians from around the world. Professor Flamen has supported the development of GE PET VCAR, an exceptional multi-modality and multi-exam comparison application to evaluate lesion metabolic activity over time.

The GE Discovery PET/CT 690 is specially designed for speed, efficiency, and PET quantification accuracy. From short exam times through optimized sensitivity system design and comprehensive imaging protocols, the Discovery PET/CT 690 is the first platform focusing on quantification accuracy without compromise by providing intelligent PET and CT iterative reconstruction, respiratory motion management solutions, and integrated PET calibration technologies. PET VCAR 2.0 is the latest visualization and analytical monitoring solution featuring both PERCIST and EORTC standards helping physicians in assessing disease progression or response to therapy.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs